Aug 01, 2019 / 08:30PM GMT
Operator
Welcome to the Acorda Therapeutics Second Quarter 2019 Updates. (Operator Instructions) Please be advised that this call is being taped at the company's request. I will now introduce your host for today's call, Felicia Vonella, Vice President of Investor Relations at Acorda. Please go ahead.
Felicia Vonella - Acorda Therapeutics, Inc. - Executive Director of IR
Thank you, Chris. Good afternoon, everyone. Before we begin, let me remind you all that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public, and we encourage you to check those filings.
Â
I will now pass the call over to our CEO, Ron Cohen. Ron?
Ron Cohen - Acorda Therapeutics, Inc. - Founder, CEO, President & Director
Thanks, Felicia. Good afternoon, everyone. We made substantial progress on the INBRIJA launch during the second quarter, and we're seeing encouraging signs that our efforts are gaining traction. We said last quarter that we believe it would take 2
Q2 2019 Acorda Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot